Green Light Filtering Glasses During Traumatic Brain Injury Rehabilitation
NCT07931638, Not applicable, Not yet recruiting, Casa Colina Hospital and Centers for Healthcare
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Green Light Filtering Glasses During Traumatic Brain Injury Rehabilitation | ClinicalTrials.gov |
| NCT number | NCT07931638 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 20 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Casa Colina Hospital and Centers for Healthcare | ClinicalTrials.gov |
| Conditions | TBI Traumatic Brain Injury | ClinicalTrials.gov |
| Interventions | Narrow-Band Green Light (NBGL) Filtering Glasses | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Pittsburgh Rehabilitation Participation Scale (PRPS) Score | Assessed during each therapy session throughout each intervention period (10 days). | Therapist-rated rehabilitation participation measured using the Pittsburgh Rehabilitation Participation Scale. Higher scores indicate greater participation in therapy activities. | ClinicalTrials.gov |
| Secondary | Generalized Anxiety Disorder-7 (GAD-7) Score | Baseline (Day 0, prior to intervention) and immediately post-intervention (within 72 hours of completion). | Anxiety symptoms measured using the Generalized Anxiety Disorder-7 questionnaire. Higher scores indicate greater anxiety severity. | ClinicalTrials.gov |
| Secondary | Headache Impact Test-6 (HIT-6) Score | Baseline (Day 0, prior to intervention) and immediately post-intervention (within 72 hours of completion). | Headache-related disability and impact on daily functioning measured using the Headache Impact Test-6. Higher scores indicate greater headache burden. | ClinicalTrials.gov |
| Secondary | Insomnia Severity Index (ISI) Score | Baseline (Day 0, prior to intervention) and immediately post-intervention (within 72 hours of completion). | Sleep disturbance severity measured using the Insomnia Severity Index. Higher scores indicate greater insomnia severity. | ClinicalTrials.gov |
| Secondary | Neurobehavioral Symptom Inventory (NSI) Total Score | Baseline (Day 0, prior to intervention) and immediately post-intervention (within 72 hours of completion). | Post-concussive and neurobehavioral symptoms measured using the Neurobehavioral Symptom Inventory. Higher scores indicate greater symptom burden. | ClinicalTrials.gov |
| Secondary | Photosensitivity Assessment Inventory (PSI) Score | Baseline (Day 0, prior to intervention) and immediately post-intervention (within 72 hours of completion). | Light sensitivity symptoms measured using the Photosensitivity Assessment Inventory. Higher scores indicate greater photosensitivity. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 3
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)